One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Precision medicine: improving accuracy, reducing error
doi : 10.1016/S2213-8587(23)00293-0
Volume 11, Issue 11, November 2023, Page 783
Remission of prediabetes via lifestyle intervention
Michael Bergman a, Brenda Dorcely b
Faster and faster: meeting the challenges of delayed insulin action during pregnancy
Denice S Feig a b c
Metastases to the thyroid gland: how does this affect cytohistological diagnoses?
Liron Pantanowitz b
Time for changes in type 1 diabetes intervention trial designs
Mark A Atkinson a b, Michael J Haller b, Desmond A Schatz b, Manuela Battaglia c, Chantal Mathieu c d
Are we settling for less in nutritional policy?
Neena Prasad a, J Jaime Miranda b c
Explaining the high rate of progression from prediabetes to type 2 diabetes in China
doi : 10.1016/S2213-8587(23)00282-6
Volume 11, Issue 11, November 2023, Page 794
Explaining the high rate of progression from prediabetes to type 2 diabetes in China – Authors' reply
doi : 10.1016/S2213-8587(23)00283-8
Volume 11, Issue 11, November 2023, Pages 794-795
Jonathan Valabhji: from clinical practice to policy making and back
Talha Burki
Correction to Lancet Diabetes Endocrinol 2023; 11: 567–77
doi : 10.1016/S2213-8587(23)00288-7
Volume 11, Issue 11, November 2023, Page e13
Correction to Lancet Diabetes Endocrinol 2023; 11: 785–87
doi : 10.1016/S2213-8587(23)00295-4
Volume 11, Issue 11, November 2023, Page e13
Mechanisms of weight loss-induced remission in people with prediabetes: a post-hoc analysis of the randomised, controlled, multicentre Prediabetes Lifestyle Intervention Study (PLIS)
Arvid Sandforth MD a b c *, Prof Reiner Jumpertz von Schwartzenberg MD a b c d *, Elsa Vazquez Arreola PhD u, Robert L Hanson MD u, Gencer Sancar PhD a b c, Sarah Katzenstein MD a b c, Karl Lange candmed a b c, Prof Hubert Preißl PhD a b c, Simon I Dreher PhD a c, Cora Weigert PhD a c, Prof Robert Wagner MD a p r, Kostantinos Kantartzis MD a b c, Jürgen Machann PhD a c e, Prof Fritz Schick MD PhD a c e, Rainer Lehmann PhD a c f, Prof Andreas Peter MD a c f, Nikoletta Katsouli MSc h k, Prof Vasilis Ntziachristos PhD h k, Corinna Dannecker PhD a c, Louise Fritsche PhD a c…Prof Andreas L Birkenfeld MD a b c x â€
Faster-acting insulin aspart versus insulin aspart in the treatment of type 1 or type 2 diabetes during pregnancy and post-delivery (CopenFast): an open-label, single-centre, randomised controlled trial
Sidse K Nørgaard MD a b c, Julie C Søholm MD a b c, Prof Elisabeth R Mathiesen DMSc a b c, Prof Kirsten Nørgaard DMSc c d, Tine D Clausen PhD a e, Pernille Holmager PhD a b, Nicoline C Do PhD a b, Prof Peter Damm DMSc a c e, Assoc Prof Lene Ringholm PhD a b c
Precision medicine for cardiometabolic disease: a framework for clinical translation
Prof Paul W Franks PhD a b c d, William T Cefalu MD e, John Dennis PhD f, Prof Jose C Florez MD g h i, Prof Chantal Mathieu MD j, Robert W Morton PhD a, Martin Ridderstråle MD k, Henrik H Sillesen MD l, Prof Coen D A Stehouwer MD b n
The case for precision medicine in the prevention, diagnosis, and treatment of cardiometabolic diseases in low-income and middle-income countries
Shivani Misra FRCP PhD a b, Prof Carlos A Aguilar-Salinas PhD c d, Tinashe Chikowore PhD e f, Flemming Konradsen PhD g h, Prof Ronald C W Ma FRCP i j k, Lilian Mbau MD l, Prof Viswanathan Mohan DSc m n, Robert W Morton PhD g, Prof Moffat J Nyirenda FRCP PhD o p, Neo Tapela MD q r, Prof Paul W Franks PhD g s t u
Understanding diabetes heterogeneity: key steps towards precision medicine in diabetes
Prof Richard David Leslie FAoP a †, Prof Ronald Ching Wan Ma FRCP b c d †, Prof Paul W Franks PhD e f g h, Prof Kristen J Nadeau MD i, Prof Ewan R Pearson FRCP j, Prof Maria Jose Redondo MD k
Precision medicine of obesity as an integral part of type 2 diabetes management – past, present, and future
Lukasz Szczerbinski MD PhD a c d e f, Prof Jose C Florez MD PhD b c d g
